Across TCGA pan-cancer cohorts, PICK1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated PICK1 data layer compared with 27 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher PICK1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated PICK1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and PDAC show a favorable association.
UCEC, PDAC, and LUAD are the cancer types where PICK1 mass-spec protein most reproducibly stratifies survival.